Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
23.05
+0.11 (0.48%)
At close: Apr 10, 2026, 4:00 PM EDT
23.49
+0.44 (1.91%)
After-hours: Apr 10, 2026, 6:45 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $2.93 billion as of April 10, 2026. Its market cap has increased by 1,247.22% in one year.
Market Cap
2.93B
Enterprise Value
2.66B
1-Year Change
1,247.22%
Ranking
Category
Stock Price
$23.05
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $2.93B, an increase of 225.08%. That is a compound annual growth rate of 93.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.92B | 186.39% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.09B |
| Oruka Therapeutics | 3.07B |
| Tarsus Pharmaceuticals | 3.06B |
| Arcutis Biotherapeutics | 3.05B |
| Dyne Therapeutics | 3.03B |
| Travere Therapeutics | 2.93B |
| Vera Therapeutics | 2.88B |
| Tango Therapeutics | 2.86B |